Myriad, Intermountain Healthcare Partner on MDx Evaluation
May 22, 2012
Myriad, Intermountain Healthcare Partner on MDx Evaluation
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Medicare Administrator Issues Draft Decision Adding Myriad's Prolaris Test to Non-covered Service
September 24, 2012 / GenomeWeb Daily News - Myriad Genetics Licenses Cancer Dx Technology from Chronix
May 10, 2011 / GenomeWeb Daily News - Prostate Cancer MDx Competition Heating Up; New Data from Genomic Health, Myriad
May 15, 2013 / Pharmacogenomics Reporter - Myriad to Replace BRACAnalysis, Other Hereditary Cancer Tests with MyRisk Panel
May 9, 2013 / GenomeWeb Daily News - Continuing Revenue Growth in Third Quarter, Myriad Keeps Focus on Diversifying MDx Product Portfolio
May 8, 2013 / Pharmacogenomics Reporter